Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

by Argiris, Athanassios, Harrington, Kevin J., Tahara, Makoto, Schulten, Jeltje, Chomette, Pauline, Ferreira Castro, Ana, Licitra, Lisa
Published in Front Oncol (2017)

Cetuximab and Radiotherapy in Laryngeal Preservation for Cancers of the Larynx and Hypopharynx: A Secondary Analysis of a Randomized Clinical Trial

by Bonner, James, Giralt, Jordi, Harari, Paul, Spencer, Sharon, Schulten, Jeltje, Hossain, Anwar, Chang, Shao-Chun, Chin, Steve, Baselga, José
Published in JAMA Otolaryngol Head Neck Surg (2016)

Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effec...

by Ferris, Robert L., Lenz, Heinz-Josef, Trotta, Anna Maria, García-Foncillas, Jesús, Schulten, Jeltje, Audhuy, François, Merlano, Marco, Milano, Gerard
Published in Cancer Treat Rev (2017)

p16, HPV, and Cetuximab: What Is the Evidence?

by Bonner, James A., Mesia, Ricard, Giralt, Jordi, Psyrri, Amanda, Keilholz, Ulrich, Rosenthal, David I., Beier, Frank, Schulten, Jeltje, Vermorken, Jan B.
Published in Oncologist (2017)

Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell...

by Rosenthal, David I., Harari, Paul M., Giralt, Jordi, Bell, Diana, Raben, David, Liu, Joyce, Schulten, Jeltje, Ang, Kian K., Bonner, James A.
Published in J Clin Oncol (2016)

Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment fr...

by Bonner, James A., Giralt, Jordi, Harari, Paul M., Baselga, Jose, Spencer, Sharon, Bell, Diana, Raben, David, Liu, Joyce, Schulten, Jeltje, Ang, Kian K., Rosenthal, David I.
Published in Eur J Cancer (2016)